Skip to main content

BNT162b2 Vaccination Linked to Lower Risk for COVID-19 Encounters in Children Under 5

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Sept. 15, 2023 -- For children younger than 5 years, receiving two or three doses of the wild-type BNT162b2 vaccine is associated with a reduced risk for COVID-19 encounters in the emergency department or urgent care or in outpatient settings, according to a research letter published online Sept. 15 in the Journal of the American Medical Association.

Sara Y. Tartof, Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues estimated the association between receipt of the wild-type BNT162b2 vaccine and medically attended COVID-19 outcomes among children younger than 5 years. Data were included for 24,261 emergency department, urgent care, or outpatient acute respiratory infection encounters (48, 29, and 23 percent, respectively) during the study period.

The researchers found that 10 percent had positive test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 6 percent were vaccinated. Overall, 3.3 and 6.3 percent of cases and controls (without positive test results for SARS-CoV-2), respectively, were vaccinated with two or three doses of BNT162b2. For children who received two or three doses of BNT162b2, the adjusted odds ratio was 0.70, 0.60, and 0.67 for a COVID-19-related emergency department or urgent care encounter, outpatient visits, and either outcome, respectively. The risk for a positive test result for SARS-CoV-2 during emergency department or urgent care and outpatient encounters among those who received two and three doses was 0.56 and 0.88, respectively.

"Updated vaccines will likely be needed to maintain protection against contemporary omicron strains in young children," the authors write.

Several authors disclosed ties to pharmaceutical companies, including Pfizer, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season

WEDNESDAY, May 22, 2024 -- In fall/winter 2023/2024, the risk for death in patients hospitalized for COVID-19 was greater than the risk for death in patients hospitalized for...

Global Life Expectancy, Disease Burden Set to Keep Improving

WEDNESDAY, May 22, 2024 -- Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease...

Preparedness for HPAI A(H5N1) Virus Varies Across Jurisdictions

TUESDAY, May 21, 2024 -- Variation is seen in preparedness and response to highly pathogenic avian influenza (HPAI) A(H5N1) viruses, according to a research letter published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.